(MENAFN) The UAE drug maker Julphar increased assets value up to USD884.57 million in 2014 as the government pushes for more locally manufactured medicine, The National reported.
The manufacturer of generic medicines now has assets worth USD884.57 million, compared with USD830.13 million in 2013. The drug maker reported sales of USD389.21 million in 2014, up by 5.3 percent year- on-year.
In 2014, Julphar said it would invest in property, plant and equipment additions and spent USD7.48 million on these during the first half. Its total investment was USD25.9 million during the period.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.